This afternoon we watched Eli Lilly and Company drop -2.2% to a price of $553.08 per share. The large-cap Pharmaceutical company is now trading -8.37% below its average target price of $603.57. Analysts have set target prices ranging from $340.0 to $710.0 per share for Eli Lilly and Company, and have given the stock an average rating of buy.
Eli Lilly and Company's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 0.8%. The stock's short ratio is 1.99. The company's insiders own 0.15% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.
Another number to watch is the company's rate of institutional share ownership, which now stands at 84.0%. In conclusion, we believe there is mixed market sentiment regarding Eli Lilly and Company.
Institutions Invested in Eli Lilly and Company
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2023-09-30 | Lilly Endowment, Inc | 11% | 99,983,810 | $55,299,047,343 |
| 2023-06-30 | Vanguard Group Inc | 7% | 69,915,764 | $38,669,011,947 |
| 2023-06-30 | Blackrock Inc. | 7% | 64,451,724 | $35,646,960,611 |
| 2023-06-30 | PNC Financial Services Group, Inc. | 5% | 51,869,805 | $28,688,152,635 |
| 2023-06-30 | State Street Corporation | 4% | 33,878,417 | $18,737,475,453 |
| 2023-06-30 | FMR, LLC | 3% | 32,798,289 | $18,140,078,240 |
| 2023-06-30 | Capital World Investors | 3% | 26,867,581 | $14,859,922,158 |
| 2023-06-30 | Price (T.Rowe) Associates Inc | 3% | 24,160,959 | $13,362,943,616 |
| 2023-06-30 | Primecap Management Company | 2% | 23,546,201 | $13,022,933,251 |
| 2023-06-30 | State Farm Mutual Automobile Insurance Co | 2% | 17,363,691 | $9,603,510,515 |
